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Figure S1 Cell viability following treatment of MG-132 and BAY11-7082.
HeLa cells were treated with MG-132 and BAY11-7082 at 2.5 mM and 10 mM, respectively.
After 24-h incubation, cell viability was determined by AlamarBlue assay. Cell viabilities of DMSO-treated cells were normalized to 100%. These data are expressed as the means ± S.D. (n=4). (A-C) H1299 cells were pre-treated with BAY11-7082 and MG-132 at 10 mM and 2.5 mM, respectively, for 1 h, followed by infection with WT-Ad or Adv-CMVLuc at 100 VP/cell. After 12-h incubation, the E1A, E2, E3, and E4 mRNA levels in the cells were determined by quantitative RT-PCR (A, C). After
24-h incubation, Ad genome copy numbers in the cells were determined by real-time PCR (B). (D, E)
H1299 cells were transfected with sip50 at 50 nM, followed by infection with WT-Ad at 100 VP/cell.
After 12-h incubation, Ad gene mRNA levels in the cells were similarly determined (D). After 24-h incubation, Ad genome copy numbers in the cells were similarly determined (E). These data are expressed as the means ± S.D. (n=3-4). **p<0.01, ***p<0.001. ** ** *** *
